Drew Weissman

University City Science Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

85h-index38.2kcitations375works18.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA Interference and Gene Delivery(126), HIV Research and Treatment(68), Immunotherapy and Immune Responses(61), SARS-CoV-2 and COVID-19 Research(59), Immune Cell Function and Interaction(43)

Publications375 total

An influenza HA mRNA-LNP vaccine induces potent responses in newborn nonhuman primates that enhance protection from challenge
npj Vaccines·2025· 1 citedOpen Access
Fractalkine-conjugated mRNA LNPs induce expression of homing molecules in cytotoxic effector CD8+ T cells 4515
The Journal of Immunology·2025Open Access
In vivo reprogramming of cytotoxic effector CD8 <sup>+</sup> T cells via fractalkine-conjugated mRNA-LNP
2025Open Access
Anionic lipids modulate mRNA-lipid nanoparticle immunogenicity and confer protection in a mouse model of multiple sclerosis
2025· 1 citedOpen Access
Consistent Induction of Broadly Neutralizing HIV Antibodies by a Novel Two-Step Mechanism Informs Immunogen Design
2025· 1 citedOpen Access
SRSF3 knockdown-induced cellular senescence as a possible therapeutic strategy for non-small cell lung cancer
Carcinogenesis·2025
In vivo chimeric antigen receptor (CAR)-T cell therapy
Nature Reviews Drug Discovery·2025· 16 cited
Lipid nanoparticle co-delivery of mRNA and a small molecule drug for oral cancer chemoimmunotherapy
2025Open Access
Allergen-specific mRNA–lipid nanoparticle therapy for prevention and treatment of experimental allergy in mice
Journal of Clinical Investigation·2025· 3 citedOpen Access
Modeling Fibrosis with MASH Patient Liver-Derived Organoids
2025Open Access
Hepatitis C virus modified <sub>S</sub> E2 <sub>F442NYT</sub> -mRNA-LNP candidate vaccine promotes helper CXCR5 <sup>+</sup> T cells
Journal of Virology·2025Open Access
Room-Temperature Preservation of mRNA using Deep Eutectic Solvent
2025Open Access
Room-Temperature Preservation of mRNA using Deep Eutectic Solvent
2025Open Access
Immunogenicity and safety of ‘Comvigen’, a bivalent SARS-CoV-2 vaccine, in comparison to Comirnaty bivalent vaccine in Thailand: a phase 2, non-inferiority randomised trial
The Lancet Regional Health - Southeast Asia·2025Open Access
Harnessing mRNA-lipid nanoparticles as innovative therapies for autoimmune diseases
Molecular Therapy — Methods & Clinical Development·2025· 9 citedOpen Access
Homologous and Heterologous Vaccination Regimens with mRNA and rVSV Platforms Induce Potent Immune Responses Against SFTSV Glycoprotein
Viruses·2025· 4 citedOpen Access
Targeting Porcine Liver Endothelium with Lipid Nanoparticles to Improve Xenograft Survival
American Journal of Transplantation·2025
Author Correction: Mannich reaction-based combinatorial libraries identify antioxidant ionizable lipids for mRNA delivery with reduced immunogenicity
Nature Biomedical Engineering·2025· 1 citedOpen Access
mRNA-LNP vaccine encoding the Plasmodium vivax circumsporozoite protein is highly immunogenic and confers protection in mice
Molecular Therapy — Nucleic Acids·2025· 1 citedOpen Access
Mannich reaction-based combinatorial libraries identify antioxidant ionizable lipids for mRNA delivery with reduced immunogenicity
Nature Biomedical Engineering·2025· 7 cited
page 1 of 19Next →

Frequent Co-authors

Norbert Pardi(21), Katalin Karikó(20), Hiromi Muramatsu(15), Ying K. Tam(15), Mohamad‐Gabriel Alameh(11), Barbara L. Mui(10), Houping Ni(7), Thomas D. Madden(7), Michael J. Hogan(6), Michael J. Hope(6), Barton F. Haynes(6), Florian Krammer(6), Scott E. Hensley(5), Paul Bates(5), John Capodici(4), Laura L. Sutherland(4), Robert Parks(4), Gregory D. Sempowski(4), Mark G. Lewis(4), István Tombácz(4)